analyst
PT
NASDAQ · PTCT
PTC Therapeutics, Inc.
Healthcare · Biotechnology
$62.34
Down-$0.24 (-0.38%)
Updated Sep 24, 2026, 4:53 PM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 6.05B
- P/E ratio
- 7.87
- Dividend yield
- 0.00%
- 52-week range
- $60.28 – $90.87
- Volume
- 1.1M
- Avg. volume
- 1.55M
Price performance
PTCT price history
1M range · 20 trading sessions · Daily adjusted prices
PTCT closed at $62.34 after 20 trading sessions, down 14.24% for the selected period.
- Last close
- $62.34
- Period change
- -14.24%
- Period low
- $62.34
- Period high
- $72.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | $65.80 | $66.1523 | $62.24 | $62.34 | 1.1M |
| Sep 22, 2026 | $66.24 | $66.58 | $65.36 | $65.96 | 1.31M |
| Sep 21, 2026 | $65.93 | $66.21 | $64.99 | $65.26 | 1.09M |
| Sep 18, 2026 | $68.00 | $68.005 | $65.18 | $65.37 | 3.86M |
| Sep 17, 2026 | $68.84 | $68.84 | $67.22 | $68.00 | 1.12M |
| Sep 16, 2026 | $65.99 | $67.90 | $65.795 | $67.59 | 1.4M |
| Sep 15, 2026 | $66.51 | $66.54 | $65.06 | $65.65 | 1.03M |
| Sep 14, 2026 | $67.09 | $67.99 | $65.91 | $66.48 | 1.02M |
| Sep 11, 2026 | $67.80 | $68.48 | $65.91 | $66.06 | 792.89K |
| Sep 10, 2026 | $66.84 | $67.78 | $66.47 | $67.37 | 1.01M |
| Sep 9, 2026 | $68.08 | $68.84 | $67.50 | $67.57 | 1.07M |
| Sep 8, 2026 | $67.81 | $70.08 | $67.475 | $68.81 | 1.12M |
| Sep 4, 2026 | $70.62 | $71.405 | $69.26 | $69.30 | 673.54K |
| Sep 3, 2026 | $71.76 | $71.97 | $70.55 | $71.40 | 654.52K |
| Sep 2, 2026 | $71.15 | $72.68 | $69.835 | $71.79 | 902.58K |
| Sep 1, 2026 | $69.42 | $70.84 | $69.05 | $70.56 | 691.02K |
| Aug 31, 2026 | $69.98 | $70.42 | $68.755 | $69.54 | 841.1K |
| Aug 28, 2026 | $71.08 | $71.49 | $69.61 | $70.09 | 692.68K |
| Aug 27, 2026 | $72.11 | $72.66 | $70.91 | $71.81 | 746.33K |
| Aug 26, 2026 | $73.18 | $73.525 | $71.81 | $72.69 | 533.67K |
Latest PTCT news
The latest Smart Investors Daily articles mentioning PTCT.
Stock researchCompany · Financials
Loading stock research…